Can Exchange Transfusions Using Red Blood Cells from Donors with Hemoglobin E Trait Prevent or Ameliorate Severe Malaria in Patients with Multi-drug Resistant Plasmodium falciparum?
- 48 Downloads
Compliance with ethical standards
Conflict of interest
Ryan Jajosky is the CEO and part-owner of Biconcavity Inc. Philip Jajosky is CFO and part-owner of Biconcavity Inc, a biotechnology research and development company exploring drug-linked-erythrocytes. This company does not have any interest in Hemoglobin E or malaria.